Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs Estrella Immunopharma, Inc. (ESLA)

Actuate Therapeutics, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Estrella Immunopharma, Inc. are of similar size ($18.0M and $17.8M). Across the 7 metrics below, Actuate Therapeutics, Inc. leads on 4 and Estrella Immunopharma, Inc. on 3.

Valuation

Metric ACTU ESLA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 7.72 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (271.88%) (65.92%) (32.88%)
Free cash flow yield (259.67%) (58.98%) (23.13%)

Profitability

Metric ACTU ESLA Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,457.65% 148.05% (51.96%)
Return on assets (336.18%) (416.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACTU ESLA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 67.48% (188.78%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ACTU ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 0.20 4.97
Net debt to EBITDA 0.59 0.11 1.01

Dividend

Metric ACTU ESLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACTU ESLA Biotechnology median
Market cap 17.98m 17.84m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack